We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,091

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

Avon shareholders reject request to “ditch toxic cosmetics”

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 10 2013

According to a Securities and Exchange Commission report, Avon Products, Inc. shareholders have rejected a proposal filed by Green Century Equity

Nanoparticles in everyday items inhibit fat storage and accelerate aging

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 10 2013

New research conducted by Stony Brook University scientists reportedly reveals that "pure gold nanoparticles found in everyday items such as personal

Germany seeks stricter nanomaterial reporting rules under REACH

  • Shook Hardy & Bacon LLP
  • -
  • European Union, Germany
  • -
  • May 10 2013

German safety regulators have apparently sought a major nanotechnologyrelated revision of the European Union's Registration, Evaluation

Scientists push for global action on EDCs

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • May 10 2013

A group of scientists has written a letter to the United Nations Environment Program (UNEP), World Health Organization (WHO), Organization for

Putative class alleges pharma statements about new drug violated securities laws

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts

Increased intake of folate, vitamin B12 and methionine may lower breast cancer risk

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 10 2013

A recent study has concluded that "higher intake of folate is marginally associated with a lower risk for estrogen receptor negative ER- breast

Global personal care products industry expected to hit $630 billion by 2017

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • May 10 2013

International research firm Research and Markets has issued a report which observes that the "global personal care products industry" has experienced

NIOSH sets nanomaterials exposure level

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • May 10 2013

The National Institute for Occupational Safety and Health (NIOSH) has set exposure guidelines (current intelligence bulletin CIB 65) for

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy